Recurrent Bladder Cancer


Keytruda Immunotherapy Improves Overall Survival in Bladder Cancer (November 10, 2016)

Bladder cancer will be diagnosed in approximately 77,000 people in the United States this year alone. The average age that patients are diagnosed with bladder cancer is 70 years, with 80% of these patients... Continue Reading

Durvalumab Granted Breakthrough Therapy Designation by US FDA for Treatment of Patients with PD-L1 Positive Urothelial Bladder Cancer (February 19, 2016)

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for durvalumab (MEDI4736), an investigational human monoclonal antibody directed against programmed death ligand-1... Continue Reading

Votrient® plus Taxol® Promising in Relapsed and Refractory Bladder Cancer (March 30, 2015)

The treatment combination of Votrient® (pazopanib) plus Taxol® (paclitaxel) appears active against bladder cancer that has not responded to or come back after previous therapy. These findings were presented... Continue Reading

Cyramza® plus Taxotere® Promising in Advanced Bladder Cancer (March 16, 2015)

The treatment combination of Cyramza® (ramucirumab) plus Taxotere® (docetaxel) appears to extend progression-free survival in patients with advanced bladder cancer that has relapse after previous treatment.... Continue Reading

Survival Benefit with Immediate Adjuvant Chemotherapy in Invasive Bladder Cancer (June 23, 2014)

Results from a recent Phase III clinical trial suggest that patients with invasive bladder cancer may benefit from treatment with immediate adjuvant chemotherapy. These finding were presented at the 2014... Continue Reading

Experimental Drug Shows Promise for Treatment of Metastatic Bladder Cancer (June 12, 2014)

According to results of a Phase I trial presented at the 2014 annual meeting of the American Society of Clinical Oncology, an investigative drug, MPDL3280A, demonstrates promise for the treatment of PD-L1... Continue Reading

Robotic Bladder Cancer Surgery Safe and Effective (January 24, 2013)

Robotic-assisted surgery for invasive bladder cancer is effective and results in less bleeding and shorter hospital stays when compared to the traditional open procedure, according to the results of a... Continue Reading

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

Results from a randomized Phase III study indicate that whole-brain radiation therapy (WBRT) following removal of one to three brain metastases with surgery or radiosurgery does not improve overall survival... Continue Reading

Cystoscopy Alone Is the Most Cost-effective Way to Monitor for Recurrence of Bladder Cancer (March 9, 2010)

The addition of a urine test to standard cystoscopy screening in order to monitor for bladder cancer recurrence unnecessarily increases the cost of monitoring as well as the risk for a false-positive result... Continue Reading

Cancer Caregivers Devote Substantial Time and Effort (September 9, 2009)

On average, informal caregivers of cancer patients devote more than eight hours per day to caregiving. These results were published in Cancer. Informal caregiving is an important part of cancer management.... Continue Reading

Intravesical Taxotere® Effective in Recurrent Superficial Bladder Cancer (July 21, 2006)

Intravesical Taxotere® Effective in Recurrent Superficial Bladder Cancer According to an article recently published in the Journal of Clinical Oncology, administration of the chemotherapy agent Taxotere®... Continue Reading

Molecular Technique May Improve Detection of Bladder Cancer Recurrences (May 22, 2006)

Molecular Technique May Improve Detection of Bladder Cancer Recurrences According to a review published in the journal Urology, a laboratory technique known as fluorescence in situ hybridization (FISH)... Continue Reading

Addition of NMP22® BladderChek® Improves Detection of Recurrent Bladder Cancer (January 18, 2006)

Addition of NMP22® BladderChek® Improves Detection of Recurrent Bladder Cancer According to a recent article published in the Journal of the American Medical Association, the addition of the NMP22®... Continue Reading

Aggressive Surgical Treatment of Bladder Cancer Benefits Patients over the Age of 80 (September 9, 2004)

Aggressive Surgical Treatment of Bladder Cancer Benefits Patients over the Age of 80 Researchers from the University of Michigan have reported that aggressive surgical management of bladder cancer in patients... Continue Reading

Alimta® Provides Responses in Recurrent Bladder Cancer (December 1, 2003)

Alimta® Provides Responses in Recurrent Bladder Cancer According to results presented at the Chemotherapy Foundation Symposium XXI, Alimta® (pemetrexed) appears to be an active agent... Continue Reading

Further Evidence Supporting Taxotere® plus Gemzar® in Inoperable Bladder Cancer (November 17, 2003)

Further Evidence Supporting Taxotere® plus Gemzar® in Inoperable Bladder Cancer According to a recent article published in the journal Cancer, the chemotherapy combination Taxotere®... Continue Reading

Immunocyt” Enhances Detection of Bladder Cancer (February 17, 2003)

Immunocyt” Enhances Detection of Bladder Cancer According to a recent article published in The Journal of Urology, the addition of Immunocyt™ to standard testing for bladder cancer... Continue Reading

Urine Test May Accurately Detect Bladder Cancer Recurrence (September 25, 2002)

Urine Test May Accurately Detect Bladder Cancer Recurrence According to recent results published in the International Journal of Cancer, a urine test that can detect a genetic mutation (error)... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS